CHARACTERIZE CANCER
Epigenomics can enable more targeted, personalized treatment strategies, providing critical insights into tumor heterogeneity, disease progression and treatment response.
Studies have shown novel epigenomic biomarkers can reveal:
Adverse Event1 or
Response Prediction2,3
Enhanced Patient Identification4
Tumor Subtyping5
Tumor of Origin5
See our latest posters on
novel epigenomic biomarkers.
Unlock novel epigenomic biomarkers with Guardant Infinity
to develop more targeted, personalized treatments.
Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma GuardantINFORM for BioPharma